Targeting the Hedgehog Pathway in Cancer: Can the Spines Be Smoothened?

被引:9
作者
Ailles, Laurie [1 ]
Siu, Lillian L. [1 ]
机构
[1] Univ Toronto, Princess Margaret Hosp, Ontario Canc Inst, Drug Dev Program, Toronto, ON M5G 2M9, Canada
关键词
CHEMOTHERAPY; INHIBITION; RESISTANCE; CELLS;
D O I
10.1158/1078-0432.CCR-11-0211
中图分类号
R73 [肿瘤学];
学科分类号
100214 [肿瘤学];
摘要
Aberrant Hedgehog (Hh) pathway signaling has been suggested to play a role in the development of multiple solid tumors and hematologic malignancies. GDC-0449 is a novel first-in-human, first-in-class smoothened (SMO) inhibitor, which has completed its phase I evaluation and achieved proof of concept in tumors with Hh pathway mutations. © 2011 American Association for Cancer Research.
引用
收藏
页码:2071 / 2073
页数:3
相关论文
共 13 条
[1]
Ahnert JR, 2010, J CLIN ONCOL, V28
[2]
Learning from Jekyll to control Hyde: Hedgehog signaling in development and cancer [J].
Barakat, Monique T. ;
Humke, Eric W. ;
Scott, Matthew P. .
TRENDS IN MOLECULAR MEDICINE, 2010, 16 (08) :337-348
[3]
Essential role of stromally induced hedgehog signaling in B-cell malignancies [J].
Dierks, Christine ;
Grbic, Jovana ;
Zirlik, Katja ;
Beigi, Ronak ;
Englund, Nathan P. ;
Guo, Gui-Rong ;
Veelken, Hendrik ;
Engelhardt, Monika ;
Mertelsmann, Roland ;
Kelleher, Joseph F. ;
Schultz, Peter ;
Warmuth, Markus .
NATURE MEDICINE, 2007, 13 (08) :944-951
[4]
Pharmacokinetics of Hedgehog Pathway Inhibitor Vismodegib (GDC-0449) in Patients with Locally Advanced or Metastatic Solid Tumors: the Role of Alpha-1-Acid Glycoprotein Binding [J].
Graham, Richard A. ;
Lum, Bert L. ;
Cheeti, Sravanthi ;
Jin, Yan Jin ;
Jorga, Karin ;
Von Hoff, Daniel D. ;
Rudin, Charles M. ;
Reddy, Josina C. ;
Low, Jennifer A. ;
LoRusso, Patricia M. .
CLINICAL CANCER RESEARCH, 2011, 17 (08) :2512-2520
[5]
Intrinsic resistance of tumorigenic breast cancer cells to chemotherapy [J].
Li, Xiaoxian ;
Lewis, Michael T. ;
Huang, Jian ;
Gutierrez, Carolina ;
Osborne, C. Kent ;
Wu, Meng-Fen ;
Hilsenbeck, Susan G. ;
Pavlick, Anne ;
Zhang, Xiaomei ;
Chamness, Gary C. ;
Wong, Helen ;
Rosen, Jeffrey ;
Chang, Jenny C. .
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2008, 100 (09) :672-679
[6]
Phase I Trial of Hedgehog Pathway Inhibitor Vismodegib (GDC-0449) in Patients with Refractory, Locally Advanced or Metastatic Solid Tumors [J].
LoRusso, Patricia M. ;
Rudin, Charles M. ;
Reddy, Josina C. ;
Tibes, Raoul ;
Weiss, Glen J. ;
Borad, Mitesh J. ;
Hann, Christine L. ;
Brahmer, Julie R. ;
Chang, Ilsung ;
Darbonne, Walter C. ;
Graham, Richard A. ;
Zerivitz, Kenn L. ;
Low, Jennifer A. ;
Von Hoff, Daniel D. .
CLINICAL CANCER RESEARCH, 2011, 17 (08) :2502-2511
[7]
Targeting Hedgehog - a Cancer Stem Cell Pathway [J].
Merchant, Akil A. ;
Matsui, William .
CLINICAL CANCER RESEARCH, 2010, 16 (12) :3130-3140
[8]
Inhibition of Hedgehog Signaling Enhances Delivery of Chemotherapy in a Mouse Model of Pancreatic Cancer [J].
Olive, Kenneth P. ;
Jacobetz, Michael A. ;
Davidson, Christian J. ;
Gopinathan, Aarthi ;
McIntyre, Dominick ;
Honess, Davina ;
Madhu, Basetti ;
Goldgraben, Mae A. ;
Caldwell, Meredith E. ;
Allard, David ;
Frese, Kristopher K. ;
DeNicola, Gina ;
Feig, Christine ;
Combs, Chelsea ;
Winter, Stephen P. ;
Ireland-Zecchini, Heather ;
Reichelt, Stefanie ;
Howat, William J. ;
Chang, Alex ;
Dhara, Mousumi ;
Wang, Lifu ;
Rueckert, Felix ;
Gruetzmann, Robert ;
Pilarsky, Christian ;
Izeradjene, Kamel ;
Hingorani, Sunil R. ;
Huang, Pearl ;
Davies, Susan E. ;
Plunkett, William ;
Egorin, Merrill ;
Hruban, Ralph H. ;
Whitebread, Nigel ;
McGovern, Karen ;
Adams, Julian ;
Iacobuzio-Donahue, Christine ;
Griffiths, John ;
Tuveson, David A. .
SCIENCE, 2009, 324 (5933) :1457-1461
[9]
SIU LL, 2010, J CLIN ONCOL, V28, P2501
[10]
Cancer stem cells in solid tumours: accumulating evidence and unresolved questions [J].
Visvader, Jane E. ;
Lindeman, Geoffrey J. .
NATURE REVIEWS CANCER, 2008, 8 (10) :755-768